Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-070870
Filing Date
2025-07-25
Accepted
2025-07-25 17:00:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6153
  Complete submission text file 0001104659-25-070870.txt   7727
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Subject) CIK: 0001231457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94094 | Film No.: 251152281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GENELUX CORPORATION 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address
Szalay Aladar (Filed by) CIK: 0001937513 (see all company filings)

Type: SCHEDULE 13G/A